2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Hematology & Oncology J HEMATOL ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.4
58人评分
我要评分
声誉 9.1 影响力 8.1 速度 6.9 | |||||||||||||||||||||||||||||
| 期刊ISSN | 1756-8722 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：36.844 | |||||||||||||||||||||||||||||
| 2025-2026自引率 | 1.0%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 42.696数据由网友[oak5608]收集提供 | |||||||||||||||||||||||||||||
| h-index | 60 | |||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||
| 期刊官方网站 | https://link.springer.com/journal/13045 | |||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.springer.com/12481 | |||||||||||||||||||||||||||||
| 作者指南网址 | https://link.springer.com/journal/13045/collections | |||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Current and future therapies for triple-negative breast cancer Author: Wang, Zi-Xun; Liu, Xi-Yu; Wu, Yu-Xiao; Xiao, Yu-Ling; Ge, Li-Ping; Wu, Song-Yang; Jiang, Yi-Zhou; Shao, Zhi-Ming Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01839-x Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data Author: Lai, Ming-Yu; Wu, Hao-Xiang; He, Ming-Ming; Guan, Wen-Long; Xu, Sheng; Hu, Han; Xu, Ya-Ling; Wang, Feng-Hua; Xu, Rui-Hua; Qiu, Miao-Zhen Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01830-6 Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer Author: Liu, Chang; Zeng, Hongxi; Li, Jiarui; Zhang, Panpan; Liu, Dan; Zhang, Miao; Xue, Ran; Gong, Jifang; Zhang, Xiaotian; Sun, Yu; Shen, Lin; Qi, Changsong Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01826-2 Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity Author: Tang, Haijia; Shi, Youyang; Ge, Qintao; Wang, Rui; Yang, Jianfeng; Zhu, Yao; Liu, Sheng; Xu, Wenhao Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01814-6 | |||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Hematology & Oncology的语言要求，还能让Journal of Hematology & Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Hematology & Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（6篇） 。
提交文稿 | |||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：haematology、oncology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||||||||||
| 年文章数 | 75点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 45.33% | |||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-8722%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Hematology & Oncology顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（6篇） 。 提交文稿 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Current and future therapies for triple-negative breast cancer Author: Wang, Zi-Xun; Liu, Xi-Yu; Wu, Yu-Xiao; Xiao, Yu-Ling; Ge, Li-Ping; Wu, Song-Yang; Jiang, Yi-Zhou; Shao, Zhi-Ming Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01839-x PubMed DOI |
| 2. | Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data Author: Lai, Ming-Yu; Wu, Hao-Xiang; He, Ming-Ming; Guan, Wen-Long; Xu, Sheng; Hu, Han; Xu, Ya-Ling; Wang, Feng-Hua; Xu, Rui-Hua; Qiu, Miao-Zhen Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01830-6 PubMed DOI |
| 3. | Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer Author: Liu, Chang; Zeng, Hongxi; Li, Jiarui; Zhang, Panpan; Liu, Dan; Zhang, Miao; Xue, Ran; Gong, Jifang; Zhang, Xiaotian; Sun, Yu; Shen, Lin; Qi, Changsong Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01826-2 PubMed DOI |
| 4. | Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity Author: Tang, Haijia; Shi, Youyang; Ge, Qintao; Wang, Rui; Yang, Jianfeng; Zhu, Yao; Liu, Sheng; Xu, Wenhao Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01814-6 PubMed DOI |
| 5. | BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88L265P-induced PIM1 stability Author: Yuan, Yan; Dai, Bo; Zhong, Haoshu; Zheng, Jiajun; Fan, Zhen; Chen, Di; Wang, Qian; Wu, Hao; Li, Yuan; Zhu, Ping; Ding, Tianling; Wang, Shu; Wu, Kunpeng; Zhang, Yu; Wang, Zhenhua; Feng, Rui; Zhu, Fengping; Zheng, Kang; Qin, Zhiyong; Yang, Bojie; Chen, Hong; Lin, Xiaolei; Yao, Yu; Zhuang, Dongxiao; Shi, Zhifeng; Mao, Ying; Chen, Tong Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01812-8 PubMed DOI |
| 6. | A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies Author: Wang, Li; Liu, Jiaying; Zhou, Keshu; Li, Zengjun; Zeng, Yun; Qian, Ying; Sun, Yuping; Wu, Hui; Roerker, Lindsay; Tan, Peter; Ma, Chen; Zhou, Liwei; Duan, Xianlin; Kang, Xiaoyan; Zhao, Wei-Li Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01796-5 PubMed DOI |
| 7. | Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition) Author: Zhang, Xiaotian; Wang, Yakun; Cai, Muyan; Wang, Fenghua; Xie, Tong; Ying, Jianming; Sheng, Weiqi; Fan, Xiangshan; Qu, Xiujuan; Wang, Chang; Peng, Zhi; Ying, Jie'er; Qiu, Miaozhen; Liu, Tianshu; Liu, Yueping; Lin, Dongmei; Yao, Xiaohong; Li, Ziyu; Guan, Wenlong; Xu, Ruihua; Li, Jin; Bu, Hong; Shen, Lin Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01804-8 PubMed DOI |
| 8. | Nanotechnology-enhanced CAR-T therapy strategies in cancer, aging, and autoimmune diseases Author: Li, Hongjia; Li, Jinxin; Liu, Xiting; Wei, Xueju; Zeng, Xin; Wang, Qiwei; Han, Yingli; Huang, He; Qian, Pengxu Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01805-7 PubMed DOI |
| 9. | Cytokines and cancer-associated fibroblasts Author: Hu, Yidu; Liang, Jiaqi; Duan, Lewei; Zhu, Junkan; Shan, Guangyao; Cheng, Tao; Wu, Yingting; Tan, Lijie; Zhan, Cheng Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01801-x PubMed DOI |
| 10. | Current and future immunotherapies for NSCLC Author: Zhou, Chu-Yu; Qi, Yi-Fan; Li, Hong-Ji; Zhang, Chao; Lin, Bai-Xin; Lin, Jun-Tao; Wu, Yi-Long; Zheng, Mei-Mei; Zhong, Wen-Zhao Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01791-w PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共5条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
